AIGP Health, a Singapore-based AI healthtech company, has achieved a significant milestone by becoming the first in the country to receive Class A regulatory approval from the Health Sciences Authority (HSA) for its AI-powered clinical assistant. This approval allows AIGP Health to distribute its innovative solution to clinics and telehealth providers across Singapore and beyond.
The platform, developed by practising doctors, utilises natural language processing to assist healthcare professionals with real-time note-taking, patient data summarisation, and consultation prompts. Importantly, the system is designed to support, not replace, human clinical judgement, ensuring that all medical decisions remain under physician control, in line with HSA’s guidelines for low-risk medical software.
Dr Anindita Santosa, co-founder and CEO of AIGP Health, emphasised the significance of the approval, stating, “Regulatory approval isn’t just a milestone for us, it’s an affirmation of our belief that technology can support, not substitute, the human touch in healthcare.” This approval enables AIGP Health to transition from pilot projects to full deployment, aiming to reduce the administrative burden on doctors and improve patient care continuity.
The approval aligns with Singapore’s broader framework for responsible AI in medicine, highlighting the country’s commitment to integrating technology in healthcare whilst maintaining the essential human element. As AIGP Health expands its reach, the platform is set to enhance clinical workflows and patient outcomes across the nation.
“`
